Zoono Group Limited (AU:ZNO)
ASX:ZNO
Top Page
Zoono Group Limited
(Sydney:ZNO)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.07
▼(-18.75% Downside)
Action:ReiteratedDate:02/25/26
The score is held down primarily by weak financial performance—deep losses, negative margins, and ongoing cash burn alongside equity erosion. Technicals also point to a weak downtrend (below key moving averages with negative MACD), partially offset by oversold RSI conditions. Valuation is difficult to support because earnings are negative and no dividend yield is provided.
Positive Factors
Low financial leverage
Sustained low leverage provides structural solvency resilience and financial flexibility. With modest debt relative to equity the company has lower fixed financing obligations, reducing bankruptcy risk and making it easier to raise or reallocate capital to support operations or strategic initiatives over the medium term.
Negative Factors
Persistent negative operating cash flow
Continued operating cash burn is a durable structural weakness: the business has not generated positive internal cash flows, forcing reliance on external financing or equity issuance. This increases dilution risk and constrains reinvestment capacity, impeding sustainable scaling and operational stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low financial leverage
Sustained low leverage provides structural solvency resilience and financial flexibility. With modest debt relative to equity the company has lower fixed financing obligations, reducing bankruptcy risk and making it easier to raise or reallocate capital to support operations or strategic initiatives over the medium term.
Read all positive factors
Zoono Group Limited (ZNO) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$25.19M
Dividend YieldN/A
Average Volume (3M)153.26K
Price to Earnings (P/E)―
Beta (1Y)0.27
Revenue Growth17.41%
EPS Growth67.94%
CountryAU
Employees2
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zoono Group Limited Business Overview & Revenue Model
Company Description
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould...
How the Company Makes Money
Zoono Group Limited makes money primarily by selling Zoono-branded antimicrobial products. Revenue is generated from product sales through a mix of channels that can include direct sales to commercial/institutional customers and sales via distribu...
Zoono Group Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
54
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 950.69K | 1.16M | 960.30K | 3.07M | 8.13M | 25.22M |
| Gross Profit | -709.17K | -281.53K | -4.36M | -625.33K | 2.10M | 11.88M |
| EBITDA | -3.07M | -3.26M | -7.89M | -181.62K | -5.11M | 5.89M |
| Net Income | -3.51M | -3.64M | -8.30M | -321.97K | -10.28M | 4.40M |
Balance Sheet | ||||||
| Total Assets | 6.01M | 5.87M | 9.01M | 13.40M | 17.68M | 29.46M |
| Cash, Cash Equivalents and Short-Term Investments | 475.33K | 47.30K | 1.79M | 759.99K | 3.30M | 4.55M |
| Total Debt | 625.70K | 544.56K | 726.63K | 868.99K | 1.00M | 1.93M |
| Total Liabilities | 2.53M | 2.89M | 2.76M | 3.24M | 8.41M | 9.88M |
| Stockholders Equity | 3.47M | 2.97M | 6.24M | 10.16M | 10.00M | 19.68M |
Cash Flow | ||||||
| Free Cash Flow | -1.76M | -1.58M | -2.89M | -3.55M | -996.61K | 834.07K |
| Operating Cash Flow | -1.76M | -1.58M | -2.89M | -3.55M | -974.11K | 1.38M |
| Investing Cash Flow | 0.00 | 0.00 | -58.73K | -53.49K | -107.62K | -1.26M |
| Financing Cash Flow | 1.50M | -190.15K | 3.99M | 873.62K | -54.99K | -4.82M |
Zoono Group Limited Technical Analysis
Positive
0.08
Price Trends
0.06
Negative
0.07
Negative
0.05
Positive
Market Momentum
>-0.01
Negative
53.66
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ZNO, the sentiment is Positive. The current price of 0.08 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.06, and above the 200-day MA of 0.05, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 53.66 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ZNO.
Zoono Group Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
45 Neutral | AU$12.00M | -0.26 | 2542.90% | ― | 12.92% | 34.21% | |
44 Neutral | AU$25.19M | -7.05 | -108.90% | ― | 17.41% | 67.94% | |
44 Neutral | AU$10.56M | -1.73 | -322.76% | ― | 88.48% | 51.61% | |
42 Neutral | AU$6.66M | -0.01 | 226.76% | ― | -21.84% | 79.99% |
* Consumer Defensive Sector Average
AU:ZNO
Zoono Group Limited
0.06
0.03
106.67%
AU:SKN
Skin Elements Limited
―
―
―
AU:SPG
Food Revolution Group Ltd.
0.30
-0.09
-23.08%
AU:CCO
Fiji Kava Limited
―
―
―
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-33.33%
Zoono Group Limited Corporate Events
Zoono Releases Interim Financial Report for Half-Year Ended 31 December 2025
Feb 23, 2026
Zoono Group Limited has released its interim financial report and ASX Appendix 4D for the half-year ended 31 December 2025. The document provides condensed financial statements, directors’ commentary, auditor review information and other sta...
Zoono Clarifies Compliance Status of Planned Share Placement in Appendix 3B Update
Feb 20, 2026
Zoono Group Limited has updated its previously announced proposed issue of securities, clarifying that the share recipient was not a related party or other person captured under ASX Listing Rule 10.11 when the agreement to issue the shares was mad...
Zoono Appoints New Director With Performance-Linked Share Incentive
Feb 9, 2026
Zoono Group Limited has appointed Marc Braterman as a director effective 3 February 2026, with disclosures confirming that he currently holds no shares or indirect security interests in the company. The filing outlines that, in his role as CEO of ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.